Open access
Open access
Powered by Google Translator Translator

Dermatology

M-A: Assessment of frequency of rosacea subtypes in patients with rosacea.

13 Apr, 2022 | 09:54h | UTC

Assessment of Frequency of Rosacea Subtypes in Patients With Rosacea: A Systematic Review and Meta-analysis – JAMA Dermatology (link to abstract – $ for full-text)

Commentary: Study Evaluates Prevalence of 4 Major Rosacea Subtypes – HCPLive

 

Commentary on Twitter

 


Global burden of cutaneous melanoma in 2020 and projections to 2040.

31 Mar, 2022 | 08:11h | UTC

Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040 – JAMA Dermatology (free for a limited period)

Editorial: Melanoma Epidemiology—Pivoting to Low- and Middle-Income Countries (free for a limited period)

Commentary: Global Burden of Melanoma Considerable, Set to Rise by 2040 – HealthDay

 


RCT: Adalimumab introduction vs. methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis.

29 Mar, 2022 | 08:20h | UTC

Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study – The Lancet Rheumatology (link to abstract – $ for full-text)

Commentary: Adalimumab Addition vs. Methotrexate Escalation in Psoriatic Arthritis – RheumNow

 

Commentary on Twitter

 


RCT: Two phase 3 trials of Baricitinib for Alopecia Areata.

28 Mar, 2022 | 08:49h | UTC

Two Phase 3 Trials of Baricitinib for Alopecia Areata – New England Journal of Medicine

 

Commentary on Twitter

 


RCT: Hydrosurgical vs. conventional debridement of burns.

28 Mar, 2022 | 08:34h | UTC

Hydrosurgical and conventional debridement of burns: randomized clinical trial – British Journal of Surgery

 

Commentary on Twitter

 


Review | Imaging findings of malignant skin tumors: radiological–pathological correlation.

25 Mar, 2022 | 08:40h | UTC

Imaging findings of malignant skin tumors: radiological–pathological correlation – Insights into Imaging

 


Estimating overdiagnosis of melanoma using trends among black and white patients in the US.

24 Mar, 2022 | 08:52h | UTC

Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US – JAMA Dermatology (link to abstract – $ for full-text)

Commentary: Deadly form of skin cancer ‘overdiagnosed’ in some patients, study finds – UPI

 

Commentary from the author on Twitter (thread – click for more)

 


European guidelines on diagnosis and management of mucous membrane pemphigoid.

23 Mar, 2022 | 10:07h | UTC

Part I: European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part I – Journal of the European Academy of Dermatology and Venereology

Part II: European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part II – Journal of the European Academy of Dermatology and Venereology

 


RCT: Inhibition of Prekallikrein for hereditary angioedema.

23 Mar, 2022 | 10:02h | UTC

Inhibition of Prekallikrein for Hereditary Angioedema – New England Journal of Medicine (link to abstract – $ for full-text)

Related:

Phase 2 RCT: Prophylactic use of garadacimab in patients with hereditary angioedema.

Evaluation and Management of Angioedema in the Emergency Department

 


Vitamin B3, niacinamide and reducing skin cancer risk: what does the research say?

22 Mar, 2022 | 08:03h | UTC

Vitamin B3, niacinamide and reducing skin cancer risk: what does the research say? – The Conversation

Related: A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention – New England Journal of Medicine

 


Systematic Review: Strategies for using topical corticosteroids in children and adults with eczema.

21 Mar, 2022 | 08:33h | UTC

Strategies for using topical corticosteroids in children and adults with eczema – Cochrane Library

Summary: What is the best way to use topical corticosteroids to treat people with eczema? – Cochrane Library

 

Commentary on Twitter

 


Phase 2 RCT: Prophylactic use of garadacimab in patients with hereditary angioedema.

18 Mar, 2022 | 08:09h | UTC

Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial – The Lancet (link to abstract – $ for full-text)

Commentary: Garadacimab significantly reduces frequency of hereditary angioedema exacerbations – Physician’s Weekly

 


RCT: Oral contezolid vs. linezolid in adults with complicated skin and soft tissue infections.

18 Mar, 2022 | 07:54h | UTC

A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections – Journal of Antimicrobial Therapy (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Follow-up data from 2 randomized trials: efficacy and safety of Upadacitinib in patients with moderate to severe atopic dermatitis.

18 Mar, 2022 | 07:48h | UTC

Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials – JAMA Dermatology

 


Systematic Review: Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.

14 Mar, 2022 | 01:20h | UTC

Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome – Cochrane Library

Summary: Which treatments that affect the whole body work best to treat severe skin reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis)? – Cochrane Library

 


Review: Mycobacterial skin infection.

14 Mar, 2022 | 00:59h | UTC

Mycobacterial skin infection – Current Opinion in Infectious Diseases

 


RCT: Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis.

10 Mar, 2022 | 10:27h | UTC

Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial – The Lancet Rheumatology (link to abstract – $ for full-text)

Commentary: COMPLETE-PsA: Adding leflunomide to methotrexate may improve outcomes – medwireNews

 

Commentary on Twitter

 


Guideline: Diagnosis and therapy of vitiligo.

8 Mar, 2022 | 08:46h | UTC

S1 Guideline: Diagnosis and therapy of vitiligo – Journal of the German Society of Dermatology

 


Review articles: Cutaneous manifestations of SARS-CoV-2 infection.

7 Mar, 2022 | 00:38h | UTC

Cutaneous Manifestations of SARS-CoV-2 Infection – American Journal of Clinical Dermatology

Common skin signs of COVID-19 in adults: An update – Cleveland Clinic Journal of Medicine

 


WSES/GAIS/WSIS/SIS-E/AAST global clinical pathways for patients with skin and soft tissue infections.

7 Mar, 2022 | 00:09h | UTC

WSES/GAIS/WSIS/SIS-E/AAST global clinical pathways for patients with skin and soft tissue infections – World Journal of Emergency Surgery

 


Major burns: Part 1. Epidemiology, pathophysiology and initial management.

25 Feb, 2022 | 11:04h | UTC

Major burns: Part 1. Epidemiology, pathophysiology and initial management – BJA Education

 


Review: Pruritus in pregnancy.

23 Feb, 2022 | 09:59h | UTC

Pruritus in Pregnancy – American Journal of Clinical Dermatology

 


Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches.

23 Feb, 2022 | 10:01h | UTC

Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches – Clinical Kidney Journal

 


A Review of existing therapies for Actinic Keratosis: current status and future directions.

23 Feb, 2022 | 09:58h | UTC

A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions – American Journal of Clinical Dermatology

 


Leukonychia: What can white nails tell us?

23 Feb, 2022 | 09:57h | UTC

Leukonychia: What Can White Nails Tell Us? – American Journal of Clinical Dermatology

 


Stay Updated in Your Specialty

No spam, just news.